Graham Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,726
| Closed | -$201K | – | 1227 |
|
|
2024
Q4 | $201K | Buy |
+11,726
| New | +$201K | ﹤0.01% | 1053 |
|
|
2024
Q3 | – | Sell |
-13,544
| Closed | -$151K | – | 1035 |
|
|
2024
Q2 | $151K | Sell |
13,544
-17,730
| -57% | -$198K | ﹤0.01% | 869 |
|
|
2024
Q1 | $206K | Sell |
31,274
-6,361
| -17% | -$42K | ﹤0.01% | 866 |
|
|
2023
Q4 | $170K | Buy |
37,635
+9,430
| +33% | +$42.6K | ﹤0.01% | 836 |
|
|
2023
Q3 | $101K | Sell |
28,205
-10,727
| -28% | -$38.4K | ﹤0.01% | 922 |
|
|
2023
Q2 | $144K | Buy |
+38,932
| New | +$144K | ﹤0.01% | 849 |
|
|
2022
Q2 | – | Sell |
-185,654
| Closed | -$339K | – | 970 |
|
|
2022
Q1 | $339K | Buy |
+185,654
| New | +$339K | 0.01% | 689 |
|